** Drugmaker Durect Corp's DRRX.O shares rise ~4% to $1.05 premarket
** DRRX says it sold the Alzet product line of osmotic pumps to Lafayette Instrument Co for $17.5 mln
** Alzet pumps are small devices used in animal research to deliver drugs, hormones or other substances directly into the body over time
** DRRX used the sale to fully repay its loan with Oxford Finance LLC, co says
** Co also says that the sale strengthens its cash position, providing funds to operate until mid-2025
** As of last close, stock had risen 71.2% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。